Sylvie Boucher
- Neurology top 2%
- Parkinson's Disease Mechanisms and Treatments 2
- Cognitive Neuroscience top 2%
- Sleep and Wakefulness Research 2
- Epidemiology top 5%
- Restless Legs Syndrome Research 3
- Speech and Hearing top 10%
-
- Pain Mechanisms and Treatments 3
-
- Neuropeptides and Animal Physiology 3
-
- Drug Transport and Resistance Mechanisms 2
-
- Pharmacological Effects and Toxicity Studies 2
- Pharmaceutical studies and practices 2
Sylvie Boucher
12 papers receiving 1.0k citations
Hit Papers
Peers
Comparison fields: 5 of 68
- Neurology 659
- Cognitive Neuroscience 709
- Epidemiology 844
- Experimental and Cognitive Psychology 178
- Speech and Hearing 42
Countries citing papers authored by Sylvie Boucher
This map shows the geographic impact of Sylvie Boucher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sylvie Boucher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sylvie Boucher more than expected).
Fields of papers citing papers by Sylvie Boucher
This network shows the impact of papers produced by Sylvie Boucher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sylvie Boucher. The network helps show where Sylvie Boucher may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Sylvie Boucher, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 1 | |
| 2 | 2015 | 1 | |
| 3 | [NT-proBNP measurement on Immulite 2500 (DPC): analytical performance and comparison with Roche Diagnostics and Dade-Behring NT-proBNP immunoassays]. | 2007 | 1 |
| 4 | 1998 | 161 | |
| 5 | Clinical, polysomnographic, and genetic characteristics of restless legs syndrome: A study of 133 patients diagnosed with new standard criteriabreakdown → | 1997 | 678 |
| 6 | 1997 | 51 | |
| 7 | 1996 | 69 | |
| 8 | 1993 | 47 | |
| 9 | 1993 | 26 | |
| 10 | 1991 | 16 | |
| 11 | 1990 | 17 | |
| 12 | 1989 | 10 |
About Sylvie Boucher
Sylvie Boucher is a scholar working on Cellular and Molecular Neuroscience, Pediatrics, Perinatology and Child Health and Clinical Biochemistry, having authored 12 papers that have together received 1.1k indexed citations. Recurring topics across this work include Pain Mechanisms and Treatments (3 papers), Neuropeptides and Animal Physiology (3 papers), Restless Legs Syndrome Research (3 papers), Drug Transport and Resistance Mechanisms (2 papers), Pharmacological Effects and Toxicity Studies (2 papers), Parkinson's Disease Mechanisms and Treatments (2 papers), Sleep and Wakefulness Research (2 papers) and Pharmaceutical studies and practices (2 papers). The work is most often cited by research in Neurology (659 citations), Cognitive Neuroscience (709 citations) and Epidemiology (844 citations). Sylvie Boucher has collaborated with scholars based in Canada, France and United States. Frequent co-authors include Gilles Lavigne, Paul Lespérance, Gaétan Poirier, O Lapierre, J. Montplaisir, Anik Gosselin, Jacques Montplaisir, Pierre Rompré, Alain Nicolas and Réjean Couture. Their work appears in journals such as CHEST Journal, Journal of Pharmacology and Experimental Therapeutics and SLEEP.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.